Literature DB >> 31999798

Correction: Hybrid Adeno-Associated Viral Vectors Utilizing Transposase-Mediated Somatic Integration for Stable Transgene Expression in Human Cells.

Wenli Zhang, Manish Solanki, Nadine Müther, Melanie Ebel, Jichang Wang, Chuanbo Sun, Zsuzsanna Izsvak, Anja Ehrhardt.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0076771.].

Entities:  

Year:  2020        PMID: 31999798      PMCID: PMC6992166          DOI: 10.1371/journal.pone.0228707

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The following information is missing from the Funding statement: Dr. Zsuzsanna Izsvák was funded by European Research Council-2011-ADG-TRANSPOSOstress– 294742. Additional information was added to the Funding statement in the Correction published in 2013 [2]. The complete, correct Funding statement is as follows: DFG grant SPP 1230 (A.E.), the E-rare project Transposmart (A.E. and Z.I.), and EU Framework Programme 7 (Persistent Transgenesis)(A.E.). W.Z. was supported by a fellowship from the Chinese Scholarship Council (CSC) in cooperation with Northwestern A&F University, Yangling, China. Dr. Zsuzsanna Izsvák was funded by European Research Council-2011-ADG-TRANSPOSOstress– 294742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.

Authors:  Wenli Zhang; Manish Solanki; Nadine Müther; Melanie Ebel; Jichang Wang; Chuanbo Sun; Zsuzsanna Izsvak; Anja Ehrhardt
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

  1 in total
  1 in total

Review 1.  Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy.

Authors:  Cedric Happi Mbakam; Gabriel Lamothe; Jacques P Tremblay
Journal:  Front Med (Lausanne)       Date:  2022-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.